INTRODUCTION
S-palmitoylation of cysteine residues is a common posttranslational modification found on integral and peripheral membrane proteins, many of which are central elements in signal transduction, synaptic function, or membrane trafficking and fusion (Bijlmakers and Marsh, 2003; Smotrys and Linder, 2004) . Palmitoylation can promote stable tethering of otherwise cytosolic proteins to intracellular membranes, can contribute to altered anterograde and endocytic trafficking of integral membrane proteins (Charollais and Van Der Goot, 2009) , and, for both, can account for their lateral segregation into lipid microdomains (Melkonian et al., 1999) . Palmitoylation is the only reversible lipid modification (Magee et al., 1987) . Cycles of de-and reacylation govern the transient membrane association of peripheral membrane proteins and thereby regulate their steady-state localization, sorting, and function (Greaves and Chamberlain, 2007; Huang and El-Husseini, 2005; Rocks et al., 2006) . However, the parameters and rules that determine the localization of peripheral membrane proteins via palmitoylation and depalmitoylation in cells are unclear. Palmitoylation activity was assigned to several membrane compartments (El-Husseini et al., 2002; Fishburn et al., 1999; Rocks et al., 2005; Swarthout et al., 2005; van't Hof and Resh, 1997) , and depalmitoylation was shown to occur at least at the plasma membrane (PM) (El-Husseini et al., 2002; Rocks et al., 2005) and estimated palmitate turnover kinetics range from 1 hr (Baker et al., 2003; Lu and Hofmann, 1995) to a few minutes (Rocks et al., 2005) . Both enzymatic and nonenzymatic mechanisms of palmitoylation were proposed. It occurs spontaneously in vitro (Bañ ó et al., 1998; Quesnel and Silvius, 1994) and targets the same cysteines that are palmitoylated in cells. Structural integrity of the substrate is not required since palmitate is also transferred to corresponding short peptides (Bañ ó et al., 1998; Bizzozero et al., 2001; Quesnel and Silvius, 1994) . Recently, protein acyltransferases (PATs) were identified in yeast and subsequently in the human genome, most notably the 25 members of the mammalian DHHC protein family (Mitchell et al., 2006) . For individual candidate PATs apparent substrate selectivity was reported (Linder and Deschenes, 2007; Tsutsumi et al., 2008) , but a consensus sequence for S-palmitoylation has not yet been identified (Bijlmakers and Marsh, 2003; Smotrys and Linder, 2004) . In a proteomic screen in yeast (Roth et al., 2006) , both discrete and overlapping functionalities among the candidate PATs were shown. Acyl protein thioesterase 1 (APT-1) currently is the only thioesterase activity (TE) known to depalmitoylate in vivo (Zeidman et al., 2009 ) (P.I.H.B. and H.W., unpublished data).
Here, we delineate the critical parameters that govern the spatial organization of palmitoylated peripheral membrane proteins. By monitoring the turnover kinetics of semi-synthetic PAT/TE substrate proteins that we introduce into cells, we determine the localization, efficiency, and specificity of the core mammalian palmitoylation machinery.
RESULTS

Monolipidated Substrates for S-Palmitoylation Rapidly and Randomly Partition over All Membranes
Palmitoylated peripheral membrane proteins typically contain an irreversibly attached prenyl or myristoyl moiety in proximity to the palmitoylation site. We first questioned whether singly lipidated proteins exhibit a specific membrane distribution to facilitate their subsequent S-palmitoylation. Mutant solely farnesylated HRasC181,184S and solely myristoylated MyrSer (32 aa peptide [Navarro-Lé rida et al., 2002] ) that cannot get palmitoylated were equipped with mCherry and mCitrine, respectively, to observe their steady-state localization. In both cases, the fluorescence distribution did not show a preference for any membrane compartment, but merely reflected membrane densities ( Figure 1A ). Photoactivatable GFP-fused versions of both proteins rapidly redistributed over all membranes, reaching steady-state within the first seconds after photoactivation ( Figures 1B and 1C) . In order to confirm that the monolipidated proteins also had access to the PM, TIRF microscopy was performed on the wild-type and monolipidated mutant proteins. As expected, the fully lipidated wild-type proteins clearly showed an enrichment at the PM ( Figure 1D ). However, both monolipidated mutants also exhibited clear PM localization, establishing that they have access to this membrane. These experiments are inconsistent with the presence of receptors for monolipidated proteins on specific membrane compartments (Choy et al., 1999) . Instead, proteins with only one attached lipid rapidly and randomly sample all membranes until they are trapped because of an increase in their affinity for membranes by the acquisition of additional lipid anchors at the site of palmitoylation. This kinetic trapping (Shahinian and Silvius, 1995) is an essential aspect of the spatial organization of palmitoylated peripheral membrane proteins that can be exploited to detect the subcellular site of palmitoylation.
Subcellular Localization and Kinetics of Ras Palmitoylation
We prepared a set of semisynthetic NRas proteins that feature differentially lipid-modified heptapeptides ligated to fluorescently labeled recombinant NRas(1-181). This was achieved by employing a combination of solid phase lipopeptide synthesis and peptide-protein ligation (Figure 2A , Figure S1 available online) (Kuhn et al., 2001) . After introduction of these probes into living cells, we directly monitored their spatially resolved palmitate turnover kinetics by making use of the phenomenon of kinetic trapping (Shahinian and Silvius, 1995) that is apparent from a local probe accumulation caused by a decrease in effective diffusion. We investigated the subcellular site and the kinetics of Ras palmitoylation using CysFar, a substrate for acylation resembling depalmitoylated NRas (Figure 2A ). This solely farnesylated protein rapidly distributed over all membranes directly after injection ( Figure 2B ), similar to palmitoylation-deficient but farnesylated HRasC181,C184S ( Figures 1A and 1C) . At the same time, stable membrane anchoring of the probe at the site of palmitoylation was apparent as rapid accumulation of CysFar specifically at the Golgi with a t/2 of 14 ± 8.4 s (n = 9, Figures 2B and 2C ). Only at later time points a fluorescence increase at the PM could be observed showing that Golgi exit of the palmitoylated probe via the secretory pathway ( Figure S2A ) accounts for enrichment of palmitoylated Ras at the PM (Choy et al., 1999) . In contrast, SerFar, a probe that cannot undergo palmitoylation, nonspecifically distributed over endomembranes (Figures 2A, 2D, and 2E upper panel) . This was also observed for CysFar after blocking the cysteine with N-ethylmaleimide ( Figure S2B ). Photobleaching of SerFar at the Golgi resulted in rapid fluorescence recovery within seconds, comparable to the redistribution of palmitoylation-deficient HRasC181S,C184S ( Figure 2E , lower panel). In contrast, CysFar fluorescence recovery at the Golgi was 13-fold slower (t/2 = 29 ± 6.8 s, n = 7), showing that its Golgi pool is more stably membrane anchored as a result of palmitoylation. In cells pretreated with 2-bromopalmitate, which inhibits palmitic acid biosynthesis and thereby indirectly protein palmitoylation (Webb et al., 2000) , specific Golgi enrichment of CysFar was blocked ( Figure 2F ). Similar rapid and specific accumulation of CysFar on the Golgi was observed in COS7 and MCF7 cells (data not shown). We conclude that palmitoylation of the carboxy-terminal prenylated substrate protein Ras occurs on the time scale of seconds and is confined to the surface of the Golgi apparatus.
Palmitoylation of Peripheral Membrane Proteins at the Golgi
In order to investigate the generality of the Golgi as palmitoylation site, we asked whether the two other classes of cytosolic palmitoylatable substrates in mammals, i.e., proteins that are N-myristoylated and S-palmitoylated at the N terminus and proteins that are only S-palmitoylated (Bijlmakers and Marsh, 2003) , undergo similar rapid palmitoylation at the Golgi. We tested semisynthetic Gai1Cys, an amino-terminal palmitoylatable substrate embodying a N-myristoylated heptapeptide derived from the heterotrimeric G protein alpha i1 subunit, and semisynthetic GAP43Cys, comprising the first 20 amino acids of GAP43 including its two palmitoylatable cysteines ( Figure 3A ). Gai1Cys exhibited Golgi accumulation characteristics (t/2 = 21 ± 11 s, n = 6) comparable to CysFar and became enriched at the PM also only later after injection. Local membrane trapping was blocked by replacement of the target cysteine with serine or by the presence of 2-bromopalmitate ( Figures 3B and 3C , Figure S3 ). GAP43 lacks additional lipid anchors and might gain access to the palmitoylation machinery by a weak intrinsic membrane affinity (El-Husseini et al., 2000; Greaves et al., 2009 ). GAP43Cys, but not a serine double mutant, accumulated specifically on the Golgi but not on any other cellular membrane (t/2 = 29 ± 15 s, n = 7, Figures 3C and 3D , Figure S4A ), similar to CysFar.
We also studied a probe comprising the amino-terminal N-myristoylated heptapeptide of the Fyn kinase that was previously shown to be palmitoylated at the PM (van't Hof and Resh, 1997). FynCys, but not a serine double mutant, accumulated initially only at the Golgi (t/2 = 16 ± 4.2 s, n = 5, Figures 3A, 3C, and 3E, Figure S4B ) but not at the PM. Only at later time points enrichment of the probe at the PM occurred due to anterograde transport of palmitoylated probe via the secretory pathway (t/2 = 173 ± 64 s, n = 5). Interestingly, the PM localization of FynCys at steady state was more pronounced than that for the other probes. The longer membrane residence time of this probe indicates lower palmitate turnover kinetics, similar to those that can be imposed on HRas by increasing the number of palmitoylated cysteine residues through mutagenesis ( Figure 3C ; see below). This explains why genetically expressed full-length Fyn or Fyn(1-11) mostly localize at the PM. As expected, but contrary to a recent study (Sato et al., 2009) , temperature block of anterograde vesicular transport shifts the steady-state distribution of Fyn back toward the Golgi (Figure 3F ). Various other palmitoylated peripheral membrane proteins do not exhibit clear Golgi localization, implying that they are palmitoylated on other membrane systems. Prenylated and palmitoylated RhoB, TC10, RRas, and Rap2C typically decorate the endocytic and/or lysosomal compartment along with the PM (Kawase et al., 2006; Paganini et al., 2006 ; Pé rez-Sala et al.,
the PM (n = 5, red), using local Gai1(1-10)-Cherry intensity as reference. Plateau values were normalized to one. Quantitative ratiometric analysis of GAP43Cys accumulation at the Golgi (n = 7). 2009; Takaya et al., 2007) . We tested whether palmitoylation of these proteins nevertheless occurs on the Golgi. Indeed, a temperature block of vesicular transport resulted in a robust shift of their steadystate localization to the Golgi ( Figure 3G ). This also shows that these proteins exhibit a slower palmitate turnover, which allows them to reach the endocytic compartment via the PM. The above experiments with representative substrates of all three classes of peripheral membrane proteins, together with the data shown in Figure 2 , demonstrate that the surface of the Golgi is the predominant subcellular site of peripheral membrane protein palmitoylation in mammalian cells. It provides directionality to the acylation cycle by making use of the secretory functionality of the Golgi that targets the PM.
Homogeneous Protein Depalmitoylation
We then studied palmitate removal in cells in order to understand how the overall palmitoylation machinery controls protein localization. First, we analyzed the depalmitoylation kinetics of PalFar, a substrate for palmitate removal resembling fully lipid modified NRas (Figure 2A ). PalFar rapidly accumulated on the Golgi shortly after microinjection ( Figures 4A and 4B , Figure S5A ) with a t/2 of 27 ± 8.6 s (n = 7), which is only marginally slower than CysFar. This probe is expected to insert into all cellular membranes after microinjection, where it remains stably tethered: a situation reflected by the nonspecific membrane localization of a PalFar analog that cannot undergo de-/repalmitoylation because of a noncleavable thioether bond (HDFar, Figures 2A, 4B, and 4C ). This shows that depalmitoylation efficiently releases PalFar from all membranes before rapid diffusion and repalmitoylation results in its membrane trapping on the Golgi. PalFar also appeared at the PM a few minutes after injection as a result of anterograde transport of probe that had been repalmitoylated on the Golgi ( Figure 4A, Figures S5A and  S5B ). Photobleaching recovery kinetics of PalFar at the Golgi were similar to CysFar (Figure 4D ), confirming that PalFar was indeed depalmitoylated when reaching the Golgi, thereby showing that the injected probe is accessible for palmitate removal everywhere in the cell. 2-bromopalmitate treatment inhibited specific Golgi accumulation of PalFar ( Figure S5C ). These experiments demonstrate that both palmitoylation and depalmitoylation in cells occur within seconds and are thus at least two orders of magnitude faster than previously concluded from pulse-chase experiments (Baker et al., 2003; Linder and Deschenes, 2007; Lu and Hofmann, 1995) . In a complementary approach, we assessed whether depalmitoylation occurs as early in the acylation cycle as at the Golgi, thereby showing that it is a fully distributed process. For this, palmitoylatable constructs with different palmitate turnover rates (Lu and Hofmann, 1995; Rocks et al., 2005) fused to photoactivatable GFP were expressed. The probes were selectively photoactivated on the Golgi and the decrease in local fluorescence was followed over time (Figures 5A and 5B). Because we are photoactivating material at the Golgi, the relative decrease of local fluorescence is only affected by the clearance rate constant (k c ). The observed residence time (t/2 = 1/k c ) will be the inverse of the sum of the rate constant of clearance by the secretory pathway and the rate constant of clearance by depalmitoylation and subsequent diffusive loss. If there is no depalmitoylation at the Golgi, the observed residence time will only depend on the secretory pathway and should therefore be the same for all tested palmitoylated molecules. However, a clear correlation was found between the residence time of these proteins on the Golgi and their kinetics of palmitate turnover (see Figure S6 ): fluorescence decay of double palmitoylated and farnesylated paGFP-HRas was slowest (t/2: 157 ± 13 s, n = 6), followed by monopalmitoylated and myristoylated paGFP-Gai1 (aa 1-11; t/2: 140 ± 19 s, n = 8) and monopalmitoylated and farnesylated paGFP-NRas (t/2: 121 ± 22 s, n = 9), while the fastest fluorescence decay was observed for monopalmitoylated and farnesylated paGFPHRasC181S (t/2: 60 ± 10 s, n = 9). As a control, nonpalmitoylatable paGFP-HRasC181,184S rapidly decayed within a few seconds. Importantly, the rate constants of Golgi clearance for the monopalmitoylated C181S mutant and double-palmitoylated wild-type HRas converged in presence of palmostatin B, an inhibitor of depalmitoylation (P.I.H.B. and H.W., unpublished data), demonstrating that the differently palmitoylated probes are indeed indiscriminately sorted into Golgi exit vesicles (Figure 5C ). The correlation between the kinetics of palmitate removal and Golgi residence time clearly shows that palmitate removal already takes place at the Golgi. In fact, the depletion of paGFP-HRasC181S from the Golgi is more than one order of magnitude faster than the reported time scale of vesicle release into the secretory pathway (Hirschberg et al., 1998) . Palmitate removal on the secretory pathway/Golgi prevents a substantial fraction of palmitoylated proteins from reaching the PM, since it redirects these proteins into the acylation cycle before they can reach the PM via the secretory pathway. This short circuit in the transport cycle affects the relative steady state PM/Golgi partitioning of a palmitoylated protein and causes a stronger uncoupling of the endomembrane protein pool from the PM compartment. Indeed, incorporation of two additional palmitoylation sites to the HRas carboxy-terminus (HRas179C,183C) results in a more pronounced steady-state PM localization ( Figure 5D ), as expected for a protein with slower apparent palmitate turnover kinetics.
Substrate Specificity of the Core Palmitoylation Machinery
We have shown that the spatial organization of palmitoylated peripheral membrane proteins is controlled by the topographic organization of the de-/reacylation machinery and its high processivity. We then investigated whether the resulting specificity in localization is achieved by a generic-i.e., nonspecific-overall palmitoylation mechanism. Proteins are chiral catalysts and their selectivity to a major extent is based on recognizing the chirality of their substrates. We therefore conversed CysFar and PalFar into their stereoisomeric counterparts with amino acid configuration altered in the immediate vicinity of the palmitoylation site as an utmost test of the stereotolerance of both lipidation and delipidation. D-CysFar and D-PalFar are semisynthetic proteins that resemble CysFar and PalFar in their side-chain functionality but feature the last seven carboxy-terminal amino acids in nonnatural D-configuration ( Figure 6A ). Thereby, secondary recognition sites in the palmitoylation and depalmitoylation reaction in vicinity to the target cysteine are likely to be disrupted. However, both D-CysFar and D-PalFar rapidly accumulated on the Golgi, with kinetics indistinguishable from their L-configured counterparts ( Figures 6B and 6C ). This demonstrates that the core cellular palmitoylation and depalmitoylation machinery is not stereoselective. We asked whether palmitate transfer or removal requires any form of molecular recognition at all of structural patterns in vicinity to the target cysteine. Semisynthetic b-CysFar and b-PalFar feature heptapeptides made of b amino acids that contain an additional carbon atom between the amino and carboxy groups ( Figure 6A ) (Seebach et al., 2004) . These modifications do not affect the integrity of the side chains but at most alter the secondary structure of the carboxy-terminus of the probe, including the target cysteine itself. Moreover, the b peptide backbone is one-third longer than the natural counterpart heptapeptide. Both microinjected b-CysFar and b-PalFar were rapidly trapped on the Golgi by palmitoylation with kinetics similar to CysFar or PalFar, respectively ( Figures 6D and 6E) . We therefore conclude that no consensus sequence is involved in cellular palmitoylation and that there is no essential requirement for the de-/repalmitoylation machinery to recognize any structure on the substrate other than the target cysteine side chain. The above experiments also confirm the central role of the Golgi in cellular palmitoylation and thereby reveal the generic nature of the spatially organizing system that is constituted by the two lipid modifying activities. The specific Golgi accumulation of all probes was blocked in the presence of 2-bromopalmitate (data not shown).
We investigated the involvement of offsite recognition in palmitoyl turnover of our probes via putative motifs on the Ras-Gdomain distal to the target cysteine. First, YFP-tH, a YFP fusion of the minimal C-terminal membrane targeting sequence of and full-length mCherry-HRas exhibited an identical steady-state partitioning over the PM and the Golgi ( Figure 7A ). They therefore must have identical palmitoyl turnover kinetics arguing against recognition of the Ras G-domain by the palmitoylation machinery. Second, Gai1Cys-GFP, a probe where the amino-terminal Gai1 heptapeptide is coupled to GFP instead of truncated NRas, displayed kinetics of Golgi accumulation similar to Gai1Cys (t/2 = 18 ± 5 s, n = 5), showing that the NRas protein core is dispensable for the recognition of the heptapeptide substrate by the palmitoylation machinery ( Figure S6 ; see also Figures 3C and 3E) . Finally, we investigated whether any specificity for the palmitoylation reaction resided in the DHHC domain-containing proteins. Previous studies have suggested that the DHHC PATs have distinct, albeit overlapping, specificities (Linder and Deschenes, 2007; Roth et al., 2006; Tsutsumi et al., 2008) . Human DHHC9 and Yeast Erf2 have so far been identified as RasPATs on the basis of biochemical assays (Lobo et al., 2002; Swarthout et al., 2005) , and evidence also exists for DHHC17 and 18 (Fukata et al., 2004; Huang et al., 2004) . However, short hairpin RNA (shRNA)-mediated knockdown of DHHC9 showed no detectable effect on Ras palmitoylation, as evident from a steady steady-state localization and recovery kinetics of HRas photobleached at the Golgi that are similar to control cells (Figures 7B-7D) . We therefore used a Hidden Markov Model (HMM)-based bioinformatics approach (Smyth, 1997) to classify the 25 human DHHC proteins into different classes on the basis of biochemical data indicating their preferred protein substrates (Extended Experimental Procedures). Indeed, the HMM indicated closer relationships ( Figure S7A ) between these particular DHHC proteins with the consensus sequence ''W-X(4)-L-X(12)-TTNE'' in mammalian and yeast proteins ( Figure S7B ) that was correlated with RasPAT activity as described by previous biochemical assays. Scanning of multiple genomes with this consensus sequence revealed that the Dictyostelium genome contained only homologs of human DHHCs 1-8, and while this organism has at least 11 Ras isoforms, none have a palmitoylatable cysteine. Therefore, if indeed Ras specific PAT activity exists, human HRas should not become palmitoylated when expressed in Dictyostelium discoideum. Human HRas was however palmitoylated in Dictyostelium cells as indicated by its clear enrichment at the PM and certain internal membranes including endosomes ( Figure 7E ). The latter organelle that originates from the PM is abundantly present in Dictyostelium cells (Gerisch et al., 2004) . The enrichment of HRas on the PM and endosomes was lost upon inhibiting palmitoylation with 2-bromopalmitate, similar to the effect on mammalian cells ( Figure S3 ). FRAP kinetics showed that the relatively slow motility of HRas in Dictyostelium cells ( Figure 7F ) was consistent with that of palmitoylated HRas (t 1/2 = 183.3 ± 3.8 s) as observed in mammalian cells ( Figure 2E ). These experiments show that no specific PAT activity exists for Ras and confirm the substrate tolerance of the palmitoylation machinery.
DISCUSSION
In this study, we applied a chemical-biological approach to directly monitor dynamic palmitoylation in single cells. We uncovered the subcellular topography and the reaction dynamics of the core palmitoylation machinery in mammalian cells, thereby revealing a generic spatially organizing system that controls the subcellular localization of peripheral membrane proteins. Bulk palmitoylation occurs on the Golgi. This organelle provides directionality in the acylation cycle by allowing locally palmitoylated proteins to enter the secretory pathway from where they are targeted to the PM. Even these polylipidated proteins will eventually redistribute to all cellular membranes to reach equilibrium. This is countered by rapid and ubiquitous depalmitoylation that causes an increase in the effective diffusion of depalmitoylated proteins, and thereby mediates their continuous redirection to the Golgi from any given cellular membrane by local kinetic trapping. Remarkably, this de-/repalmitoylation machinery constitutes a spatially organizing system that does not require any form of direct ligand/receptor interaction in order to spatially segregate proteins. It dynamically maintains their spatial organization out of equilibrium by generating a directional flow from the Golgi to the PM. This counteracts the tendency of the system to increase its entropy by protein redistribution over all membranes. This directed transport acts like a conveyor belt along which palmitoylated peripheral membrane proteins are continuously enriched. The steady-state partitioning between Golgi and the PM with its interconnected endocytic compartment is dictated by the kinetics of palmitate turnover (Rocks et al., 2005) (Figures 5D, 3F , and 3G). Additional sorting signals or protein interactions could allow the palmitoylated proteins to access more specialized membrane subcompartments as for instance in neuronal cells (Huang and El-Husseini, 2005; Jura et al., 2006; Kang et al., 2008) . Numerous publications over the last few years have established the role of DHHC family proteins in protein palmitoylation in yeast and mammals. As anticipated for a typical enzyme, substrate specificity has been described for several of the DHHC proteins (Huang et al., 2009; Linder and Deschenes, 2007; Tsutsumi et al., 2008) . These findings are mostly based on changes in the palmitoylation level of a putative substrate protein observed upon co-overexpression of DHHC proteins. Our study challenges the assumption that specific individual PAT/substrate pairs are prerequisite in palmitate transfer. The experiments with D amino acids and nonnatural peptides clearly demonstrate that the sequence context flanking the target cysteine on the substrate does not contribute to substrate recognition. A recent study in yeast further supports the assumption of overlapping specificities (Hou et al., 2009) . We thus propose that, in mammalian cells, any protein is qualified for palmitoylation that contains a surface-exposed and freely accessible cysteine that has transient access to Golgi membranes. This transient Golgi membrane proximity can be accomplished by nearby myristoyl or prenyl lipid anchors or nearby transmembrane domains, by binding to other proteins that permit transient Golgi accessibility or by an intrinsic weak membrane affinity.
No matter what type of substrate protein we tested-representatives of the three types of peripheral membrane proteins or, most importantly, probes with D amino acid configuration or nonnatural peptides-we always observed rapid palmitoylation only on the surface of the Golgi. This highly efficient core palmitoylation machinery rapidly processes any available target protein with very wide substrate tolerance. Palmitoylation activities on other subcellular sites such as the PM are feasible but would be relevant only for palmitoylatable proteins that do not have repeated access to the Golgi, like transmembrane proteins. Since our probes did not detect such activities, putative nonGolgi PATs must be far less efficient than the Golgi palmitoylation machinery or might involve additional specific offsite recognition that would prevent immediate turnover on the Golgi (discussed below). However, unlike in yeast, where PATs have been found on various different endomembrane systems (Hou et al., 2009; Ohno et al., 2006) , all DHHC proteins in humans so far shown to be of enzymatic relevance localize at the Golgi (Ferná ndez-Hernando et al., 2006; Huang et al., 2009; Ohno et al., 2006) , with the exception of neuronal DHHC2 (Noritake et al., 2009) .
Why are there 25 DHHC proteins in mammals? In our study we could rule out off-site recognition as an essential feature in the cellular palmitoylation reaction and, specifically, its involvement in the palmitoylation of Ras and of small palmitoylatable peptides. However, it might contribute to the efficiency of palmitoylation. There are no obvious motifs for such recognition on the DHHC proteins distal to their active site and/or the substrates distal to the target cysteine. Only three of the 25 DHHC family members contain protein interaction domains (SH3 on DHHC6 and ankyrin repeats on DHHC13 and 17), with DHHC5/8 and DHHC14 encoding potential PDZ binding motifs (type II and type I, respectively). Therefore, distal interaction would likely involve electrostatic or hydrophobic affinity but not structural recognition. Whether this is generally relevant or only applies to special cases such as the recently shown interaction between the yeast vacuole PAT Pfa3 and its substrate Vac8 (Hou et al., 2009; Nadolski and Linder, 2009) remains to be investigated. It is also noteworthy that at least some DHHC proteins might have biological functions independent of their PAT activity as has been shown recently for the yeast DHHC protein Swf1p in polarized secretion (Dighe and Kozminski, 2008) .
Wide substrate tolerance is a known phenomenon in organic synthesis exploiting acylating and deacylating enzymes (Drauz and Waldmann, 2002) . Therefore, a nonclassical enzymatic mechanism of palmitoylation is conceivable where DHHC proteins participate in a Golgi-based machinery that coordinates the accumulation, storage, relay and presentation of palmitoylCoA and accomplishes the bulk cellular palmitate transfer. DHHC proteins have been shown to be autoacylated (Lobo et al., 2002) and may establish a continuously preformed set of thioester-charged intermediates with high acylation potential.
Once the acylated DHHC-protein encounters a substrate thiol, the thioesters are exchanged and the reaction would be driven by lateral diffusion and vesicular export of the product. Do dynamic changes in palmitate turnover rates, as observed upon extracellular stimulation (El-Husseini et al., 2002; Kang et al., 2008) , occur directly at the level of the PATs/thioesterase activity (Tsutsumi et al., 2008) ? The fast kinetics and the lack of primary substrate specificity of the palmitoylation machinery as revealed in this study do not support this notion. However, regulation of palmitate turnover rates by extrinsic cues can very well arise indirectly from changes in the accessibility of thiol or thioester groups on the substrate protein, for example upon conformational changes of the substrate or upon masking or unmasking by other proteins. Likewise conceivable, stimulusinduced remodeling of the secretory pathway could alter the transport kinetics of palmitoylated proteins cycling between the Golgi and peripheral membranes. Such changes in substrate flow rates that will ultimately translate into altered apparent palmitate turnover rates might particularly be critical for palmitoylated proteins trafficking between Golgi outposts and dendritic spines in neuronal cells (Horton and Ehlers, 2003; Kang et al., 2008) .
Our findings are relevant for drug discovery programs aimed at interference with aberrant signaling of palmitoylated proteins such as oncogenic Ras. Chemical compounds can now be identified that interfere with the palmitoylation machinery and thereby modulate oncogenic Ras signaling activity by affecting its spatial distribution (P.I.H.B. and H.W., unpublished data). Strategies to interfere with protein palmitoylation need to however consider the broad substrate tolerance in the palmitoylation reaction as delineated here.
EXPERIMENTAL PROCEDURES
Generation of Synthetic Lipoproteins
Lipopeptides synthesized on solid phase were purified, and their integrity was verified by liquid chromatography-mass spectrometry, MALDI-TOF, and proton nuclear magnetic resonance. Purification of relevant proteins and eGFP-Cys (eGFP with an additional C-terminal cysteine suiteable for the MIC ligation), subsequent MIC coupling to the lipopeptides, and quality analysis by MALDI-TOF and SDS page was performed as described elsewhere (Bader et al., 2000) (for details, see the Extended Experimental Procedures). The NRas (1-181) protein was labeled prior to coupling with Cy3 monoreactive dye pack (Amersham Biosciences).
Plasmid Constructs
Human HRas, NRas and mutants thereof, the MyrSer peptide, Fyn, GAP43, Galpha(1-10), RhoB, RRas, and TC10 were fused with fluorescent proteins into mammalian expression vectors using conventional cloning techniques. Site-directed mutagenesis provided Cys to Ser mutant forms when necessary. For a detailed description of plasmid construction, see the Extended Experimental Procedures.
Microscopy and Data Analysis
Confocal micrographs of various proteins and injected substrates were corrected for background, endomembrane cytosol volume filling factors, and segmented using masks for the relevant cellular compartments. Maximum intensities on these cellular compartments were normalized to one where appropriate and ratiometric traces were plotted against time where mentioned (for details, see the Extended Experimental Procedures).
Cell Culture, Cell Transfection and 2-Bromopalmitate Treatment MDCK cells were maintained in minimum essential medium supplemented with 10% fetal bovine serum (FBS), HeLa cells in Dulbecco's modified Eagle's medium (DMEM) with 10% FBS. Transient plasmid expression of MDCK cells was achieved by overnight transfection with Effectene (QIAGEN). HeLa cells were transfected with Fugene6 (Roche) for 6 hr and imaged 12 hr after transfection. For live cell microscopy, cells were cultured on 35 mm glass bottom dishes (MatTek, Ashland, MA). Transfected cells were serum starved for 5-6 hr in 1% FBS before all experiments and transferred to low-bicarbonate DMEM without phenol red supplemented with 25 mM HEPES (pH 7.4) for microscopy. 2-bromopalmitate (50 mM) was prediluted 1:100 before addition to the imaging medium.
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